![Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer](https://www.mdpi.com/cancers/cancers-11-01479/article_deploy/html/images/cancers-11-01479-g001.png)
Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
![Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00352-3/MediaObjects/41523_2021_352_Fig1_HTML.png)
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer
![Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease - Zerdes - 2020 - Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease - Zerdes - 2020 -](https://febs.onlinelibrary.wiley.com/cms/asset/e9ec5994-dcda-4efd-ba36-eda88545f954/mol212654-toc-0001-m.jpg)
Programmed death‐ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21‐gene and 70‐gene signatures in estrogen receptor‐positive disease - Zerdes - 2020 -
![Tumor-infiltrating lymphocytes and the PD-L1/PD-1 signaling axis in breast cancer: biology and clinical implications | Semantic Scholar Tumor-infiltrating lymphocytes and the PD-L1/PD-1 signaling axis in breast cancer: biology and clinical implications | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/472ccf8bfee0c40f358a970f256f84553441069f/20-Figure1-1.png)
Tumor-infiltrating lymphocytes and the PD-L1/PD-1 signaling axis in breast cancer: biology and clinical implications | Semantic Scholar
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
![TOKYO, JAPAN - AUGUST 2: Angelos Vlachopoulos of Greece, Konstantinos Gkiouvetsis of Greece, Christodoulos Kolomvos of Greece, Konstantinos Mourikis of Greece, Stylianos Argyropoulos of Greece, Georgios Dervisis of Greece, Alexandros Papanastasiou of TOKYO, JAPAN - AUGUST 2: Angelos Vlachopoulos of Greece, Konstantinos Gkiouvetsis of Greece, Christodoulos Kolomvos of Greece, Konstantinos Mourikis of Greece, Stylianos Argyropoulos of Greece, Georgios Dervisis of Greece, Alexandros Papanastasiou of](https://c8.alamy.com/comp/2GB28DD/tokyo-japan-august-2-angelos-vlachopoulos-of-greece-konstantinos-gkiouvetsis-of-greece-christodoulos-kolomvos-of-greece-konstantinos-mourikis-of-greece-stylianos-argyropoulos-of-greece-georgios-dervisis-of-greece-alexandros-papanastasiou-of-greece-marios-kapotsis-of-greece-dimitrios-skoumpakis-of-greece-konstantinos-genidounias-of-greece-emmanouil-zerdevas-of-greece-ioannis-fountoulis-of-greece-during-the-tokyo-2020-olympic-waterpolo-tournament-men-match-between-team-greece-and-team-united-states-at-tatsumi-waterpolo-centre-on-august-2-2021-in-tokyo-japan-photo-by-marcel-ter-2GB28DD.jpg)
TOKYO, JAPAN - AUGUST 2: Angelos Vlachopoulos of Greece, Konstantinos Gkiouvetsis of Greece, Christodoulos Kolomvos of Greece, Konstantinos Mourikis of Greece, Stylianos Argyropoulos of Greece, Georgios Dervisis of Greece, Alexandros Papanastasiou of
![Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology](https://www.researchgate.net/profile/Emmanouil-Sifakis/publication/341640726/figure/fig2/AS:967485306200065@1607677880096/Flow-chart-of-search-and-study-selection-in-the-meta-analysis-of-studies-evaluating_Q320.jpg)
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
![Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology](https://www.researchgate.net/publication/356387273/figure/fig1/AS:1094515989446656@1637964355196/TILs-manual-and-digital-evaluation-Representative-image-of-a-tissue-microarray-TMA_Q320.jpg)
Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology
![Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer](https://www.mdpi.com/cancers/cancers-13-04655/article_deploy/html/images/cancers-13-04655-g003.png)
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
Ioannis Zerdes - Civil Engineer - Self-employed engineering, management & grant consultant. | LinkedIn
![Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer](https://www.mdpi.com/cancers/cancers-13-04655/article_deploy/html/images/cancers-13-04655-g002.png)
Cancers | Free Full-Text | Discordance of PD-L1 Expression at the Protein and RNA Levels in Early Breast Cancer
![Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41523-021-00352-3/MediaObjects/41523_2021_352_Fig4_HTML.png)
Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility study | npj Breast Cancer
![Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer](https://www.mdpi.com/cancers/cancers-11-01479/article_deploy/html/images/cancers-11-01479-g004-550.jpg)
Cancers | Free Full-Text | STAT3 Activity Promotes Programmed-Death Ligand 1 Expression and Suppresses Immune Responses in Breast Cancer
![Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology Ioannis ZERDES | PostDoc / Licensed Physician | MD PhD | Karolinska Institutet, Solna | KI | Department of Oncology-Pathology](https://i1.rgstatic.net/ii/profile.image/463964455870468-1487629154886_Q512/Ioannis-Zerdes.jpg)